Simone Nardin

522 total citations
21 papers, 278 citations indexed

About

Simone Nardin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Simone Nardin has authored 21 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Simone Nardin's work include Advanced Breast Cancer Therapies (4 papers), Cancer Risks and Factors (3 papers) and Cancer Treatment and Pharmacology (3 papers). Simone Nardin is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Cancer Risks and Factors (3 papers) and Cancer Treatment and Pharmacology (3 papers). Simone Nardin collaborates with scholars based in Italy, United States and Germany. Simone Nardin's co-authors include Valentina Rossi, Sara Rubinelli, Alessandra Gennari, Chiara Saggia, Francesca D’Avanzo, Matteo Nardin, Alberto Puccini, Andreas Seeber, Matteo Pagnesi and Paolo Malerba and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Simone Nardin

17 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Nardin Italy 6 144 61 50 43 32 21 278
Valentina Rossi Italy 5 197 1.4× 68 1.1× 50 1.0× 54 1.3× 33 1.0× 8 371
Francesca D’Avanzo Italy 3 133 0.9× 52 0.9× 58 1.2× 61 1.4× 26 0.8× 8 255
Chiara Saggia Italy 6 177 1.2× 71 1.2× 65 1.3× 42 1.0× 26 0.8× 15 309
Nadeem Bilani United States 10 161 1.1× 74 1.2× 105 2.1× 82 1.9× 32 1.0× 38 364
Utku Oflazoğlu Türkiye 11 154 1.1× 44 0.7× 45 0.9× 58 1.3× 41 1.3× 41 312
Jinnan Gao China 10 124 0.9× 71 1.2× 30 0.6× 41 1.0× 13 0.4× 37 287
Alireza Rezvani Iran 8 98 0.7× 40 0.7× 47 0.9× 60 1.4× 50 1.6× 47 256
Ana Elisa Lohmann Canada 11 240 1.7× 57 0.9× 92 1.8× 167 3.9× 39 1.2× 27 397
Chen Zhu China 11 114 0.8× 73 1.2× 51 1.0× 78 1.8× 33 1.0× 36 325

Countries citing papers authored by Simone Nardin

Since Specialization
Citations

This map shows the geographic impact of Simone Nardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Nardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Nardin more than expected).

Fields of papers citing papers by Simone Nardin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Nardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Nardin. The network helps show where Simone Nardin may publish in the future.

Co-authorship network of co-authors of Simone Nardin

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Nardin. A scholar is included among the top collaborators of Simone Nardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Nardin. Simone Nardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arecco, Luca, Eva Blondeaux, Marco Bruzzone, et al.. (2025). Prognostic implications of risk definitions from the monarchE and NATALEE trials. JNCI Journal of the National Cancer Institute. 117(6). 1198–1208. 3 indexed citations
2.
Nardin, Simone, Giovanni Rossi, Giulia Barletta, et al.. (2025). Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives. Cancers. 17(4). 652–652. 3 indexed citations
3.
4.
Cardinali, Bárbara, et al.. (2025). New insight in early detection and precision medicine in small cell lung cancer: liquid biopsy as innovative clinical tool. Critical Reviews in Clinical Laboratory Sciences. 62(6). 404–428. 1 indexed citations
5.
Nardin, Simone, Andrea Delbarba, Francesca D’Avanzo, et al.. (2025). Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management. Cancers. 17(17). 2726–2726.
6.
Leone, Alberto Giovanni, Stefania Bonadonna, Chiara Cassani, et al.. (2024). Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review. SHILAP Revista de lepidopterología. 3(1). e000330–e000330. 1 indexed citations
7.
Battistuzzi, Linda, Eva Blondeaux, Francesca Poggio, et al.. (2024). Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer. BMC Palliative Care. 23(1). 129–129.
8.
9.
Nardin, Simone, Lucia Del Mastro, Maria Grazia Razeti, et al.. (2024). 125P Suboptimal ovarian suppression during adjuvant endocrine therapy for premenopausal women with breast cancer: An exploratory analysis of the PREFER and GIM 23 studies. ESMO Open. 9. 103113–103113. 1 indexed citations
10.
Nardin, Matteo, Monica Verdoia, Simone Nardin, et al.. (2024). Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes. Biomedicines. 12(4). 768–768. 13 indexed citations
11.
Puccini, Alberto, Simone Nardin, Sonia Lastraioli, et al.. (2024). Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center. European Journal of Cancer Prevention. 33(4). 355–362. 1 indexed citations
12.
Nardin, Simone, et al.. (2024). Updates in pharmacotherapy for non-small cell lung cancer: a focus on emerging tubulin inhibitors. Expert Opinion on Pharmacotherapy. 25(8). 1051–1069. 3 indexed citations
13.
Nardin, Matteo, Monica Verdoia, Davide Cao, et al.. (2023). Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary Prevention. Journal of Clinical Medicine. 12(18). 6074–6074. 5 indexed citations
14.
Malerba, Paolo, et al.. (2023). Impact of Immunity on Coronary Artery Disease: An Updated Pathogenic Interplay and Potential Therapeutic Strategies. Life. 13(11). 2128–2128. 16 indexed citations
15.
Martelli, Valentino, Fabio Catalano, Simone Nardin, et al.. (2023). The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives. Frontiers in Oncology. 13. 1161048–1161048. 23 indexed citations
16.
Nardin, Simone, et al.. (2023). Adjuvant treatment in hormone receptor-positive early breast cancer: New approaches of endocrine therapy. Tumori Journal. 110(3). 162–167. 3 indexed citations
17.
Gennari, Alessandra, Étienne Brain, Andrea De Censi, et al.. (2023). Early prediction of endocrine responsiveness in ER+/HER2 negative MBC: Pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.. Journal of Clinical Oncology. 41(16_suppl). 1024–1024.
18.
19.
Poggio, Francesca, Simone Nardin, Marta Perachino, et al.. (2023). Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered?. Expert Opinion on Pharmacotherapy. 24(18). 1975–1984. 1 indexed citations
20.
Nardin, Simone, Francesca D’Avanzo, Valentina Rossi, et al.. (2020). Breast Cancer Survivorship, Quality of Life, and Late Toxicities. Frontiers in Oncology. 10. 864–864. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valentina Rossi Breakdown of academic impact, for papers by Francesca D’Avanzo Breakdown of academic impact, for papers by Chiara Saggia Breakdown of academic impact, for papers by Nadeem Bilani Breakdown of academic impact, for papers by Utku Oflazoğlu Breakdown of academic impact, for papers by Jinnan Gao Breakdown of academic impact, for papers by Alireza Rezvani Breakdown of academic impact, for papers by Ana Elisa Lohmann Breakdown of academic impact, for papers by Chen Zhu
Rankless by CCL
2026